当前位置:首页 - 行情中心 - 迪哲医药-U(688192) - 财务分析 - 现金流量表

迪哲医药-U

(688192)

  

流通市值:257.22亿  总市值:259.42亿
流通股本:4.61亿   总股本:4.65亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金4,893,859,507.43526,503,971.43259,026,446.25784,586,671.73
  收到其他与经营活动有关的现金13,543,619.1212,673,381.5710,039,738.6961,540,755.93
  经营活动现金流入小计4,907,403,126.55539,177,353269,066,184.94846,127,427.66
  购买商品、接受劳务支付的现金434,953,786.84286,219,053.25170,800,963.71503,149,726.41
  支付给职工以及为职工支付的现金534,359,709.96333,425,918.65198,307,746.99592,176,224.91
  支付的各项税费71,501,147.647,459,426.822,003,278.540,355,616.65
  支付其他与经营活动有关的现金217,234,182.88146,380,736.5878,431,826.89298,770,648.26
  经营活动现金流出小计1,258,048,827.28813,485,135.28469,543,816.091,434,452,216.23
  经营活动产生的现金流量净额3,649,354,299.27-274,307,782.28-200,477,631.15-588,324,788.57
二、投资活动产生的现金流量:
  收回投资收到的现金5,346,425,204.083,643,441,245.911,896,479,023.29,968,752,061.49
  处置固定资产、无形资产和其他长期资产收回的现金净额95,00095,000-8,165.19
  投资活动现金流入小计5,346,520,204.083,643,536,245.911,896,479,023.29,968,760,226.68
  购建固定资产、无形资产和其他长期资产支付的现金49,664,891.2747,297,105.8934,913,521.14170,469,026.06
  投资支付的现金5,057,000,0003,541,000,0001,955,000,00010,997,000,000
  投资活动现金流出小计5,106,664,891.273,588,297,105.891,989,913,521.1411,167,469,026.06
  投资活动产生的现金流量净额239,855,312.8155,239,140.02-93,434,497.94-1,198,708,799.38
三、筹资活动产生的现金流量:
  吸收投资收到的现金---1,776,367,935.51
  取得借款收到的现金434,280,000434,280,000387,080,000810,717,810.54
  收到其他与筹资活动有关的现金38,228,080.5338,228,080.5338,228,080.5317,057,750
  筹资活动现金流入小计472,508,080.53472,508,080.53425,308,080.532,604,143,496.05
  偿还债务支付的现金369,374,930310,924,130180,305,800711,907,015.12
  分配股利、利润或偿付利息支付的现金23,503,292.0116,273,530.627,599,785.9832,891,742.85
  支付其他与筹资活动有关的现金42,777,315.6438,259,163.9411,056,291.8230,659,846.27
  筹资活动现金流出小计435,655,537.65365,456,824.56198,961,877.8775,458,604.24
  筹资活动产生的现金流量净额36,852,542.88107,051,255.97226,346,202.731,828,684,891.81
四、汇率变动对现金及现金等价物的影响-3,932,338.91-265,176.13-158,619.01-394,408.41
五、现金及现金等价物净增加额3,922,129,816.05-112,282,562.42-67,724,545.3741,256,895.45
  加:期初现金及现金等价物余额291,146,638.08291,146,638.08291,146,638.08249,889,742.63
  期末现金及现金等价物余额4,213,276,454.13178,864,075.66223,422,092.71291,146,638.08
补充资料:
  净利润--213,095,536.85--768,517,444.68
  固定资产和投资性房地产折旧-15,889,565.67-11,960,028.37
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-15,889,565.67-11,960,028.37
  无形资产摊销-16,538,725.17-33,340,462.44
  长期待摊费用摊销-1,661,379.03-7,861,748.29
  处置固定资产、无形资产和其他长期资产的损失--84,070.8--279.52
  固定资产报废损失-314.61--
  公允价值变动损失--13,673,367.04--25,326,758.27
  财务费用-16,757,042.12-31,610,196.5
  存货的减少--5,949,072.09-7,165,303.32
  经营性应收项目的减少--59,273,756.23--114,025,471.8
  经营性应付项目的增加--53,330,696.87-129,375,305.25
  其他-8,296,902.29-73,647,515.03
  现金的期末余额-178,864,075.66-291,146,638.08
  减:现金的期初余额-291,146,638.08-249,889,742.63
  现金及现金等价物的净增加额--112,282,562.42-41,256,895.45
公告日期2026-10-312026-08-212026-04-302026-03-31
审计意见(境内)标准无保留意见
TOP↑